PortalPublikationen[Treatment strategy in non-testicular malignant germ cell tu...

[Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology]

Standard

[Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology]. / Göbel, U; Haas, R J; Harms, D; Janka-Schaub, Gritta; Brämswig, J; Jürgens, H; Weissbach, L; Faber, P; Müller, E.

in: KLIN PADIATR, Jahrgang 195, Nr. 3, 3, 1983, S. 201-206.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Göbel, U, Haas, RJ, Harms, D, Janka-Schaub, G, Brämswig, J, Jürgens, H, Weissbach, L, Faber, P & Müller, E 1983, '[Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology]', KLIN PADIATR, Jg. 195, Nr. 3, 3, S. 201-206. <http://www.ncbi.nlm.nih.gov/pubmed/6192281?dopt=Citation>

APA

Göbel, U., Haas, R. J., Harms, D., Janka-Schaub, G., Brämswig, J., Jürgens, H., Weissbach, L., Faber, P., & Müller, E. (1983). [Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology]. KLIN PADIATR, 195(3), 201-206. [3]. http://www.ncbi.nlm.nih.gov/pubmed/6192281?dopt=Citation

Vancouver

Göbel U, Haas RJ, Harms D, Janka-Schaub G, Brämswig J, Jürgens H et al. [Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology]. KLIN PADIATR. 1983;195(3):201-206. 3.

Bibtex

@article{735640be474e4203b9a14f54c2da93eb,
title = "[Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology]",
abstract = "In December 1982 the German Society of Pediatric Oncology (GPO) has initiated a cooperative study for non-testicular malignant germ cell tumors with initial vinblastine, bleomycin and cisplatinum chemotherapy depending on stage and histological grading, followed by ifosfamide, cisplatinum and VP 16 chemotherapy. Dysgerminoma patients with advanced disease are also treated with primary chemotherapy including vinblastine, bleomycin and cisplatinum; radiotherapy is limited to current disease. Patients with more differentiated teratomas receive combination chemotherapy with vinblastine, actinomycin D and cyclophosphamide.",
author = "U G{\"o}bel and Haas, {R J} and D Harms and Gritta Janka-Schaub and J Br{\"a}mswig and H J{\"u}rgens and L Weissbach and P Faber and E M{\"u}ller",
year = "1983",
language = "Deutsch",
volume = "195",
pages = "201--206",
journal = "KLIN PADIATR",
issn = "0300-8630",
publisher = "Georg Thieme Verlag KG",
number = "3",

}

RIS

TY - JOUR

T1 - [Treatment strategy in non-testicular malignant germ cell tumors in children and adolescents--concept of the MAKEI 83 cooperative therapeutic study of the Society for Pediatric Oncology]

AU - Göbel, U

AU - Haas, R J

AU - Harms, D

AU - Janka-Schaub, Gritta

AU - Brämswig, J

AU - Jürgens, H

AU - Weissbach, L

AU - Faber, P

AU - Müller, E

PY - 1983

Y1 - 1983

N2 - In December 1982 the German Society of Pediatric Oncology (GPO) has initiated a cooperative study for non-testicular malignant germ cell tumors with initial vinblastine, bleomycin and cisplatinum chemotherapy depending on stage and histological grading, followed by ifosfamide, cisplatinum and VP 16 chemotherapy. Dysgerminoma patients with advanced disease are also treated with primary chemotherapy including vinblastine, bleomycin and cisplatinum; radiotherapy is limited to current disease. Patients with more differentiated teratomas receive combination chemotherapy with vinblastine, actinomycin D and cyclophosphamide.

AB - In December 1982 the German Society of Pediatric Oncology (GPO) has initiated a cooperative study for non-testicular malignant germ cell tumors with initial vinblastine, bleomycin and cisplatinum chemotherapy depending on stage and histological grading, followed by ifosfamide, cisplatinum and VP 16 chemotherapy. Dysgerminoma patients with advanced disease are also treated with primary chemotherapy including vinblastine, bleomycin and cisplatinum; radiotherapy is limited to current disease. Patients with more differentiated teratomas receive combination chemotherapy with vinblastine, actinomycin D and cyclophosphamide.

M3 - SCORING: Zeitschriftenaufsatz

VL - 195

SP - 201

EP - 206

JO - KLIN PADIATR

JF - KLIN PADIATR

SN - 0300-8630

IS - 3

M1 - 3

ER -